Newsletter
Site Engagement Newsletter
In this edition, read insights and updates from PRA’s Site Engagement Team. We explore the role of Clinical Trial Liaisons and how their work…
All Results
Newsletter
White Paper
Bridging the Diversity Gap with Decentralized Trials
The current drug development research paradigm is flawed in that it fails to include a diverse and representative patient population. A new approach…
Blog
PRA Health Sciences and Deep Lens, Inc. partner to accelerate patient recruitment for precision cancer trials.
This strategic relationship brings together best-in-class technologies that improve the identification, screening, and matching of cancer patients to…
Blog
Including Children in COVID-19 Trials: Challenges and Opportunities
You may have heard the buzz surrounding a new severe inflammatory condition observed in children that seems to be connected with COVID-19 infection.…
Blog
Understanding the Patient Voice Through Social Listening
What does the patient voice actually sound like? PRA is answering that question by studying how patients, caregivers, and healthcare providers talk…
Blog
Challenges Arise as the Need for Pediatric Research Increases
Many modern providers prescribe off-label treatment to children with “guesstimated” doses, because these drugs have often only been studied in…
Case Study
PRA’s Unique Model Leads to Client Satisfaction
A randomized, multi-center, double-blind study to compare the efficacy and safety of Study Drug A and Study Drug B as monotherapy in newly diagnosed…
Page
Clinical Trial Manager
A PRA Clinical Trial Manager leads and manages the execution of one or more clinical studies from study startup through database release. As a core…
Page
Corporate Responsibility
We’re in the business of improving lives, but drug development isn’t the only way we’re doing it. While bringing new treatments to market is…
Page
Predictivv™
The landscape of clinical development is continually evolving, but the end goal of trial design hasn’t changed. As a global CRO, our priority is to…